BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37087107)

  • 21. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.
    Shi Y; Yamada K; Liddelow SA; Smith ST; Zhao L; Luo W; Tsai RM; Spina S; Grinberg LT; Rojas JC; Gallardo G; Wang K; Roh J; Robinson G; Finn MB; Jiang H; Sullivan PM; Baufeld C; Wood MW; Sutphen C; McCue L; Xiong C; Del-Aguila JL; Morris JC; Cruchaga C; ; Fagan AM; Miller BL; Boxer AL; Seeley WW; Butovsky O; Barres BA; Paul SM; Holtzman DM
    Nature; 2017 Sep; 549(7673):523-527. PubMed ID: 28959956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microglial APOE4: more is less and less is more.
    Eskandari-Sedighi G; Blurton-Jones M
    Mol Neurodegener; 2023 Dec; 18(1):99. PubMed ID: 38115077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.
    Cole GM; Ard MD
    Microsc Res Tech; 2000 Aug; 50(4):316-24. PubMed ID: 10936886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropathological correlates and genetic architecture of microglial activation in elderly human brain.
    Felsky D; Roostaei T; Nho K; Risacher SL; Bradshaw EM; Petyuk V; Schneider JA; Saykin A; Bennett DA; De Jager PL
    Nat Commun; 2019 Jan; 10(1):409. PubMed ID: 30679421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer's disease and age-matched non-demented brains.
    Ojo JO; Reed JM; Crynen G; Vallabhaneni P; Evans J; Shackleton B; Eisenbaum M; Ringland C; Edsell A; Mullan M; Crawford F; Bachmeier C
    Mol Brain; 2021 Jul; 14(1):110. PubMed ID: 34238312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation.
    Lanfranco MF; Sepulveda J; Kopetsky G; Rebeck GW
    Glia; 2021 Jun; 69(6):1478-1493. PubMed ID: 33556209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of APOE genotype on prion-type propagation of tauopathy.
    Williams T; Ruiz AJ; Ruiz AM; Vo Q; Tsering W; Xu G; McFarland K; Giasson BI; Sullivan P; Borchelt DR; Chakrabarty P
    Acta Neuropathol Commun; 2022 Apr; 10(1):57. PubMed ID: 35440098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice.
    Balu D; Valencia-Olvera AC; Nguyen A; Patnam M; York J; Peri F; Neumann F; LaDu MJ; Tai LM
    Alzheimers Res Ther; 2023 Oct; 15(1):181. PubMed ID: 37858252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOE genotype-dependent modulation of astrocyte chemokine CCL3 production.
    Cudaback E; Yang Y; Montine TJ; Keene CD
    Glia; 2015 Jan; 63(1):51-65. PubMed ID: 25092803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.
    Wolfe CM; Fitz NF; Nam KN; Lefterov I; Koldamova R
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An exhausted-like microglial population accumulates in aged and APOE4 genotype Alzheimer's brains.
    Millet A; Ledo JH; Tavazoie SF
    Immunity; 2024 Jan; 57(1):153-170.e6. PubMed ID: 38159571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
    Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoform-Specific Effects of Apolipoprotein E on Markers of Inflammation and Toxicity in Brain Glia and Neuronal Cells In Vitro.
    Iannucci J; Sen A; Grammas P
    Curr Issues Mol Biol; 2021 May; 43(1):215-225. PubMed ID: 34071762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenomic features related to microglia are associated with attenuated effect of APOE ε4 on Alzheimer's disease risk in humans.
    Ma Y; Yu L; Olah M; Smith R; Oatman SR; Allen M; Pishva E; Zhang B; Menon V; Ertekin-Taner N; Lunnon K; Bennett DA; Klein HU; De Jager PL
    Alzheimers Dement; 2022 Apr; 18(4):688-699. PubMed ID: 34482628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice.
    Ophir G; Meilin S; Efrati M; Chapman J; Karussis D; Roses A; Michaelson DM
    Neurobiol Dis; 2003 Feb; 12(1):56-64. PubMed ID: 12609489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoform-specific proteolysis of apolipoprotein-E in the brain.
    Elliott DA; Tsoi K; Holinkova S; Chan SL; Kim WS; Halliday GM; Rye KA; Garner B
    Neurobiol Aging; 2011 Feb; 32(2):257-71. PubMed ID: 19278755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination.
    Wang N; Wang M; Jeevaratnam S; Rosenberg C; Ikezu TC; Shue F; Doss SV; Alnobani A; Martens YA; Wren M; Asmann YW; Zhang B; Bu G; Liu CC
    Mol Neurodegener; 2022 Nov; 17(1):75. PubMed ID: 36419137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia.
    Li X; Montine KS; Keene CD; Montine TJ
    FASEB J; 2015 May; 29(5):1754-62. PubMed ID: 25593125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating the synergistic effects of hormone replacement therapy, apolipoprotein E and age on brain health in the UK Biobank.
    Ambikairajah A; Khondoker M; Morris E; de Lange AG; Saleh RNM; Minihane AM; Hornberger M
    Hum Brain Mapp; 2024 Feb; 45(2):e26612. PubMed ID: 38339898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.